OBJECTIVE—In mice, 4F, an apolipoprotein A-I mimetic peptide that restores HDL function, prevents diabetes-induced atheroscle-rosis. We sought to determine whether HDL function is impaired in type 2 diabetic (T2D) patients and whether 4F treatment im-proves HDL function in T2D patient plasma in vitro. RESEARCH DESIGN ANDMETHODS—HDL anti-inflammatory function was determined in 93 T2D patients and 31 control subjects as the ability of test HDLs to inhibit LDL-induced monocyte che-motactic activity in human aortic endothelial cell monolayers. The HDL antioxidant properties were measured using a cell-free assay that uses dichlorofluorescein diacetate. Oxidized fatty acids in HDLs were measured by liquid chromatography–tandem mass spectrometry. ...
Objective: HDL (high-density lipoprotein) infusion reduces atherosclerosis in animal models and is b...
Aims/hypothesis In type 2 diabetes mellitus (T2DM), the abnormal protein and lipid composition of di...
Background Type 2 diabetes mellitus increases the risk of atherosclerotic cardiovascular disease. An...
OBJECTIVE—In mice, 4F, an apolipoprotein A-I mimetic peptide that restores HDL function, prevents di...
OBJECTIVE—In mice 4F, an apolipoprotein A-I mimetic peptide that restores HDL function prevents diab...
ObjectiveIn mice, 4F, an apolipoprotein A-I mimetic peptide that restores HDL function, prevents dia...
Features of end-stage renal disease such as oxidative stress, inflammation, hypertension, and dyslip...
Background: Functional properties of high density lipoproteins (HDL) are increasingly recognized to ...
Background and Aims. Apolipoprotein A-I (ApoA-I), the main component of high-density lipoprotein (HD...
Abstract Background Functional properties of high density lipoproteins (HDL) are increasingly recogn...
ObjectivesOur aim was to investigate the effects of reconstituted high-density lipoprotein (rHDL) in...
ObjectiveTo determine the effect of the apolipoprotein A-I (ApoA-I) mimetic peptide, D-4F, on athero...
Cardiovascular and pulmonary diseases are leading causes of morbidity and mortality worldwide. Studi...
BACKGROUND: Despite robust cholesterol lowering, cardiovascular disease risk remains increased in pa...
Objective: High density lipoprotein (HDL) cholesterol levels are inversely related to cardiovascular...
Objective: HDL (high-density lipoprotein) infusion reduces atherosclerosis in animal models and is b...
Aims/hypothesis In type 2 diabetes mellitus (T2DM), the abnormal protein and lipid composition of di...
Background Type 2 diabetes mellitus increases the risk of atherosclerotic cardiovascular disease. An...
OBJECTIVE—In mice, 4F, an apolipoprotein A-I mimetic peptide that restores HDL function, prevents di...
OBJECTIVE—In mice 4F, an apolipoprotein A-I mimetic peptide that restores HDL function prevents diab...
ObjectiveIn mice, 4F, an apolipoprotein A-I mimetic peptide that restores HDL function, prevents dia...
Features of end-stage renal disease such as oxidative stress, inflammation, hypertension, and dyslip...
Background: Functional properties of high density lipoproteins (HDL) are increasingly recognized to ...
Background and Aims. Apolipoprotein A-I (ApoA-I), the main component of high-density lipoprotein (HD...
Abstract Background Functional properties of high density lipoproteins (HDL) are increasingly recogn...
ObjectivesOur aim was to investigate the effects of reconstituted high-density lipoprotein (rHDL) in...
ObjectiveTo determine the effect of the apolipoprotein A-I (ApoA-I) mimetic peptide, D-4F, on athero...
Cardiovascular and pulmonary diseases are leading causes of morbidity and mortality worldwide. Studi...
BACKGROUND: Despite robust cholesterol lowering, cardiovascular disease risk remains increased in pa...
Objective: High density lipoprotein (HDL) cholesterol levels are inversely related to cardiovascular...
Objective: HDL (high-density lipoprotein) infusion reduces atherosclerosis in animal models and is b...
Aims/hypothesis In type 2 diabetes mellitus (T2DM), the abnormal protein and lipid composition of di...
Background Type 2 diabetes mellitus increases the risk of atherosclerotic cardiovascular disease. An...